Contact Us

Sherie Morrison, UCLA David Geffen School of Medicine, to Speak at ImmunoTx Summit

Sherie Morrison, Distinguished Professor at UCLA David Geffen School of Medicine, will present, "Antibody Fusions with Interferon for the Treatment of Malignancy" at GTCbio's ImmunoTx Summit
    BOSTON, MA, November 30, 2016 /24-7PressRelease/ -- Sherie Morrison, Distinguished Professor at UCLA's David Geffen School of Medicine, will give a presentation on "Antibody Fusions with Interferon for the Treatment of Malignancy" at GTCbio's 9th Immunotherapeutics & Immunomonitoring Conference, which is happening on February 6-7, 2016 at the Hard Rock Hotel in San Diego, CA.

Type I interferons (IFN-alpha/IFN-beta) exhibit multiple potent anti-tumor properties. An attractive approach to improving efficacy while reducing toxicity is to deliver IFN to the site of the tumor by fusing it to an antibody specific for a tumor associated antigen (TAA). Dr. Morrison's lab found IFN fusion proteins to be effective therapeutics when targeted to TAAs on a number of different cancers.

Dr. Morrison is among the leading scientific and clinical experts from academia and industry to speak at the 9th Immunotherapeutics & Immunomonitoring Conference. New immunological concepts with clinically translational implications will be discussed, along with evaluations of novel drug targets and therapeutic approaches, the role of biomarkers in immunomonitoring, and the latest data on combinatorial treatments in the clinic.

This conference is also part of our larger ImmunoTx Summit, which consists of the following conferences:

9th Immunotherapeutics & Immunomonitoring Conference
5th Immunogenicity & Immunotoxicity Conference
15th Cytokines & Inflammation Conference

For more information, please visit website:

635 W. Foothill Blvd
Monrovia, CA 91016
Phone: (626) 256-6405
Fax: (626) 466-4433

# # #

Contact Information

Jan Lee

Monrovia, California
United States
Voice: 626-256-6405
E-Mail: Email Us Here
Website: Visit Our Website

Like This Story?

I like it! 0


If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release Newswire. We are unable to assist you with any information regarding this release. 24-7 Press Release Newswire disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.